查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1224511

基因合成市场规模、份额和趋势分析:方法(固相合成、芯片合成、PCR基底□合成)、服务、应用、用途、地区、市场、2023-2030年

Gene Synthesis Market Size, Share & Trends Analysis Report By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By Service, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 176 Pages | 商品交期: 2-10个工作天内

价格

基因合成市场的增长和趋势

Grand View Research, Inc. 的最新报告预测，2023 年至 2030 年全球基因合成市场规模将以 16.1% 的复合年增长率增长，到 2030 年将达到 57.8 亿美元。 市场的发展是由于合成生物学领域投资的增加、有利的政府法规以及基因合成市场的技术进步。 2022 年 1 月，合成 DNA 製造商 Twisted Biosciences 在 J.P. Morgan Healthcare Conference 上宣布了开发 EDS 技术的计划。 公司建立了一种新颖、低成本、无疤痕、高度可扩展的□促 DNA 合成技术。

为了满足研究人员日益增长的需求，引入具有技术先进规格的新 DNA 合成平台也促进了整体增长。 例如，2021年6月，DNAscript发布了基于EDS技术的核酸打印机SYNTAX System。 同样，2020 年 12 月，Evonetics, Inc. 与 Analog Devices, Inc. 进行了研究合作。 根据协议，两家公司将在 Evonetix 基于微机电系统的硅芯片的改进和商业化以及 DNA 桌面写入器的开发方面进行合作。

近年来，不仅是研究人员，生物技术和製药公司也对靶向治疗产生了更大的兴趣。 近年来，研究人员、生物技术公司和製药公司对靶向治疗的兴趣越来越大，它们作为疾病管理的工具越来越受到关注。 在不久的将来，靶向疗法结合化学疗法和免疫疗法具有显着发展的潜力，为基因合成市场的新兴和老牌竞争者提供了良好的前景。

主要参与者专注于产品开发并建立合作伙伴关係和协作以扩展其产品范围。 例如，2022 年 1 月，Thermo Fisher Scientific 完成了对抗体和载体生产商 PeproTech, Inc. 的收购。 此次收购可以帮助公司巩固其市场地位。 同样，2021 年 7 月，金斯瑞举办了金斯瑞基因与细胞工程虚拟峰会。 该活动将使公司能够扩大其客户群，重点关注合成生物学研究，以增强蛋白质设计、药物发现和基因组编辑。

基因合成市场报告亮点

对合成生物学的需求不断增长以及政府对合成生物学研究和开发的资金支持不断增加是推动该市场增长的因素

在方法方面，固相合成在 2022 年占据主导地位，因为它具有高精度，是一种适用于各个领域和各种研究目的的强大技术

按服务划分，抗体 DNA 合成在 2022 年主导了基因合成市场。 这是由于重要参与者的存在，如 Synbio 提供服务、Twist Bioscience Corporation 等，它们在这一领域提供服务。

按应用划分，基因和细胞疗法开发领域在 2022 年主导了基因合成市场。 这是由于越来越多的细胞和基因治疗开发研究和开发计划

就最终用途而言，学术和政府研究机构将在 2022 年主导基因合成市场，因为大部分基因合成过程将在临床研究和试验项目的研究环境中进行

p>

由于其完善的分子生物学基础设施和该地区众多市场参与者的存在，北美将在 2022 年占据最高份额。

目次

第 1 章基因合成市场：研究方法和范围

  • 市场细分
    • 细分范围
    • 区域范围
  • 调查方法
  • 资讯采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要资讯
    • 初步调查
    • 初步调查的详细资讯
  • 资讯或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细资讯
    • 商品流分析
      • 方法 1：商品流方法
      • 方法 2：使用自下而上的方法按国家/地区进行市场预测
      • 方法 3：使用自上而下的方法逐个国家/地区进行市场估算
  • 全球市场：CAGR 计算
  • 区域市场：CAGR 计算
  • 次要资讯列表
  • 目的
  • 缩写列表

第 2 章基因合成市场：执行摘要

  • 基因合成市场：市场展望
    • 市场概览

第 3 章基因合成市场：行业展望

  • 市场系列展望
    • 母市场沿袭预测
    • 相关/子公司市场前景
  • 描绘渗透率和增长前景
  • 市场动态
    • 市场促进因素
      • 增加对合成生物学市场的投资
      • □促 DNA 合成过程的出现
      • DNA 合成平台的技术进步
      • DNA 合成和测序的价格下降
    • 市场抑制因素分析
      • 缺乏熟练的专业人员
      • 滥用基因合成
  • SWOT 分析，按因素（政治和法律、经济和技术）
  • 行业分析 - 波特五力分析
  • 报销和监管场景
  • 主要交易和战略联盟
    • 新产品发布
    • 取得
    • 分机
    • 伙伴关係
    • 营销和推广

第 4 章基因合成市场：竞争格局

  • 主要市场进入者的近期发展和影响分析
    • Ansoff Matrix
  • 公司分类
    • 创新者
      • 市场差异化因素
  • 供应商概况
    • 主要分销商和渠道合作伙伴列表
    • 主要客户
    • 2022 年主要参与者的市场份额分析
  • 上市公司
    • 竞争仪錶盘分析
  • 私人公司
    • 主要初创企业名单
  • 本地网络地图

第 5 章基因合成市场：方法业务分析

  • 基因合成市场：方法变异分析
  • 固相合成
  • 基于芯片的合成
  • 基于 PCR 的□促合成

第 6 章基因合成市场：服务业务分析

  • 基因合成市场：服务波动分析
  • 抗体DNA合成
  • 病毒DNA合成
  • 其他

第 7 章基因合成市场：应用业务分析

  • 基因合成市场：应用的变化分析
  • 基因和细胞疗法的发展
  • 疫苗开发
  • 疾病诊断
  • 其他

第 8 章基因合成市场：最终用途业务分析

  • 基因合成市场：最终用途变异分析
  • 生物技术和製药公司
  • 学术研究机构和政府研究机构
  • 委託研究机构

第 9 章基因合成市场：区域业务分析

  • 北美
    • SWOT 分析
    • 美国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 加拿大
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 欧洲
    • SWOT 分析：
    • 德国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 英国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 法国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 意大利
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 西班牙
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 丹麦
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 瑞典
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 挪威
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 亚太地区
    • SWOT 分析：
      • 主要区域动态
    • 日本
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 中国
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 印度
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 韩国
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 澳大利亚
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 泰国
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 拉丁美洲
    • SWOT 分析：
    • 主要地区动态
    • 巴西
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 墨西哥
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 阿根廷
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 中东和非洲 (MEA)
    • SWOT 分析：
    • 主要地区动态
    • 南非
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 沙特阿拉伯
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 阿拉伯联合酋长国
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 科威特
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景

第 10 章基因合成市场：公司概况

  • 公司简介
    • GenScript
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Brooks Automation, Inc. (GENEWIZ)
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Boster Biological Technology
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Twist Bioscience
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • ProteoGenix, Inc.
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Biomatik
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • ProMab Biotechnologies, Inc.
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Thermo Fisher Scientific, Inc.
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Integrated DNA Technologies, Inc.
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • OriGene Technologies, Inc.
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
  • 其他主要参与者名单
Product Code: GVR-4-68039-597-3

Gene Synthesis Market Growth & Trends:

The global gene synthesis market size is expected to reach USD 5.78 billion by 2030, registering a CAGR of 16.1% from 2023 to 2030 according to a new report by Grand View Research, Inc. Development of the market is due to the growing investment in the synthetic biology field, favorable government regulations, and technological advancements in the gene synthesis market. In January 2022, synthetic DNA manufacturer Twist Bioscience announced plans of developing EDS technology at the J.P. Morgan Health Care Conference. The company established an enzymatic DNA synthesis technology that is novel, low-cost, scarless, and scalable.

The introduction of novel DNA synthesis platforms with technologically advanced specifications that address the increased demand of researchers is also contributing to the overall growth. For instance, in June 2021, DNA Script introduced the SYNTAX System, which is the nucleic acid printer based on EDS technology. Similarly, in December 2020, Evonetix Ltd. entered into a research collaboration with Analog Devices, Inc. Under the terms of the agreement, the companies collaborated on Evonetix's Microelectromechanical System-based silicon chips' improvement and commercial scale-up, as well as the development of a DNA desktop writer.

Researchers, as well as biotechnology and pharmaceutical corporations, have become increasingly interested in targeted therapy during recent years. It has become a popular method of disease management. In the near future, targeted therapy in conjunction with chemotherapy and immunotherapy is likely to develop significantly, presenting lucrative prospects for both emerging & established competitors in the gene synthesis market.

Key players are focusing on product development and are entering into partnerships and collaborations to expand their product offerings. For instance, In January 2022, Thermo Fisher Scientific, Inc. completed the acquisition of PeproTech, Inc.- a producer of antibodies and vectors. This acquisition may help the company strengthen its position in the market. Similarly, in July 2021, GenScript hosted the GenScript Gene & Cell Engineering Virtual Summit. This event focused on highlighting synthetic biology research to enhance protein design, drug discovery, and genome editing, enabling the company to increase its customer base.

Gene Synthesis Market Report Highlights:

  • The growth is attributed to the growing demand for the synthetic biology, coupled with increasing government support to offer funds for R&D initiatives in synthetic biology
  • By method, solid-phase synthesis dominated in 2022 as it offers high accuracy and is a prominent technology for the applications in several fields and for various research purposes
  • By services, antibody DNA synthesis dominated the gene synthesis market in 2022, owing to the presence of significant players such as Synbio offers services, Twist Bioscience Corporation, and others, offering services in this segment
  • By application, the gene & cell therapy development segment dominated the gene synthesis market in 2022. This is attributed to the growing number of R&D programs for the development of cell and gene therapies
  • By end-use, academic and government research institute dominated the gene synthesis market in 2022, as most of the gene synthesis process is performed in the research settings for clinical research and investigational programs
  • North America captured the highest share in 2022 owing to the well-established molecular biology infrastructure along with the presence of a significant number of market players in the region

Table of Contents

Chapter 1 Gene Synthesis Market: Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
      • 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Regional Market: CAGR Calculation
  • 1.9 List Of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:
  • 1.11 List of Abbreviations

Chapter 2 Gene Synthesis Market: Executive Summary

  • 2.1 Gene Synthesis Market: Market Outlook
    • 2.1.1 Market Summary

Chapter 3 Gene Synthesis Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Rising investment in synthetic biology market
      • 3.3.1.2 Advent of enzymatic DNA synthesis process
      • 3.3.1.3 Technological advancements in the DNA synthesis platforms
      • 3.3.1.4 Declining price of DNA synthesis & sequencing
    • 3.3.2 Market restraint Analysis
      • 3.3.2.1 Lack of skilled professionals
      • 3.3.2.2 Misuse of gene synthesis
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 Gene Synthesis Market: Competitive Landscape

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Ansoff Matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List Of Key Distributors And Channel Partners
    • 4.3.2 Key Customers
    • 4.3.3 Key Company Market Share Analysis, 2022
  • 4.4 Public Companies
    • 4.4.1 Competitive Dashboard Analysis
  • 4.5 Private Companies
    • 4.5.1 List Of Key Emerging Companies
  • 4.6 Regional Network Map

Chapter 5 Gene Synthesis Market: Method Business Analysis

  • 5.1 Gene Synthesis Market: Method Movement Analysis
  • 5.2 Solid-phase Synthesis
    • 5.2.1 Solid-phase Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3 Chip-based Synthesis
    • 5.3.1 Chip-based Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4 PCR-based Enzyme Synthesis
    • 5.4.1 PCR-based Enzyme Synthesis market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Gene Synthesis Market: Services Business Analysis

  • 6.1 Gene Synthesis Market: Services Movement Analysis
  • 6.2 Antibody DNA Synthesis
    • 6.2.1 Antibody DNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3 Viral DNA Synthesis
    • 6.3.1 Viral DNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Gene Synthesis Market: Application Business Analysis

  • 7.1 Gene Synthesis Market: Application Movement Analysis
  • 7.2 Gene & Cell Therapy Development
    • 7.2.1 Gene & Cell Therapy Development market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3 Vaccine Development
    • 7.3.1 Vaccine Development market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4 Disease Diagnosis
    • 7.4.1 Disease Diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Gene Synthesis Market: End-use Business Analysis

  • 8.1 Gene Synthesis Market: End-use Movement Analysis
  • 8.2 Biotechnology and Pharmaceutical Companies
    • 8.2.1 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3 Academic and Government Research Institutes
    • 8.3.1 Academic And Government Research Institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4 Contract Research Organizations
    • 8.4.1 Contract Research Organizations market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Gene Synthesis Market: Regional Business Analysis

  • 9.1 North America
    • 9.1.1 Swot Analysis
      • 9.1.1.1 North America Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.1.2 U.S.
      • 9.1.2.1 Key Country Dynamics
      • 9.1.2.2 Target Disease Prevalence
      • 9.1.2.3 Competitive Scenario
      • 9.1.2.4 Regulatory Framework
      • 9.1.2.5 Reimbursement Scenario
      • 9.1.2.6 U.S. Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.1.3 CANADA
      • 9.1.3.1 Key Country Dynamics
      • 9.1.3.2 Target Disease Prevalence
      • 9.1.3.3 Competitive Scenario
      • 9.1.3.4 Regulatory Framework
      • 9.1.3.5 Reimbursement Scenario
      • 9.1.3.6 Canada Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2 Europe
    • 9.2.1 SWOT Analysis:
      • 9.2.1.1 Europe Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2 Germany
      • 9.2.2.1 Key Country Dynamics
      • 9.2.2.2 Target Disease Prevalence
      • 9.2.2.3 Competitive Scenario
      • 9.2.2.4 Regulatory Framework
      • 9.2.2.5 Reimbursement Scenario
      • 9.2.2.6 Germany Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3 UK
      • 9.2.3.1 Key Country Dynamics
      • 9.2.3.2 Target Disease Prevalence
      • 9.2.3.3 Competitive Scenario
      • 9.2.3.4 Regulatory Framework
      • 9.2.3.5 Reimbursement Scenario
      • 9.2.3.6 UK Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4 FRANCE
      • 9.2.4.1 Key Country Dynamics
      • 9.2.4.2 Target Disease Prevalence
      • 9.2.4.3 Competitive Scenario
      • 9.2.4.4 Regulatory Framework
      • 9.2.4.5 Reimbursement Scenario
      • 9.2.4.6 France Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.5 Italy
      • 9.2.5.1 Key Country Dynamics
      • 9.2.5.2 Target Disease Prevalence
      • 9.2.5.3 Competitive Scenario
      • 9.2.5.4 Regulatory Framework
      • 9.2.5.5 Reimbursement Scenario
      • 9.2.5.6 Italy Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.6 Spain
      • 9.2.6.1 Key Country Dynamics
      • 9.2.6.2 Target Disease Prevalence
      • 9.2.6.3 Competitive Scenario
      • 9.2.6.4 Regulatory Framework
      • 9.2.6.5 Reimbursement Scenario
      • 9.2.6.6 Spain Cell & Gene Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.7 Denmark
      • 9.2.7.1 Key Country Dynamics
      • 9.2.7.2 Target Disease Prevalence
      • 9.2.7.3 Competitive Scenario
      • 9.2.7.4 Regulatory Framework
      • 9.2.7.5 Reimbursement Scenario
      • 9.2.7.6 Denmark Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.8 Sweden
      • 9.2.8.1 Key Country Dynamics
      • 9.2.8.2 Target Disease Prevalence
      • 9.2.8.3 Competitive Scenario
      • 9.2.8.4 Regulatory Framework
      • 9.2.8.5 Reimbursement Scenario
      • 9.2.8.6 Sweden Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.9 Norway
      • 9.2.9.1 Key Country Dynamics
      • 9.2.9.2 Target Disease Prevalence
      • 9.2.9.3 Competitive Scenario
      • 9.2.9.4 Regulatory Framework
      • 9.2.9.5 Reimbursement Scenario
      • 9.2.9.6 Norway Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3 Asia Pacific
    • 9.3.1 Swot Analysi:
      • 9.3.1.1 Key Region Dynamics
      • 9.3.1.2 Asia Pacific Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2 Japan
      • 9.3.2.1 Target Disease Prevalence
      • 9.3.2.2 Competitive Scenario
      • 9.3.2.3 Regulatory Framework
      • 9.3.2.4 Reimbursement Scenario
      • 9.3.2.5 Japan Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3 China
      • 9.3.3.1 Target Disease Prevalence
      • 9.3.3.2 Competitive Scenario
      • 9.3.3.3 Regulatory Framework
      • 9.3.3.4 Reimbursement Scenario
      • 9.3.3.5 China Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4 India
      • 9.3.4.1 Target Disease Prevalence
      • 9.3.4.2 Competitive Scenario
      • 9.3.4.3 Regulatory Framework
      • 9.3.4.4 Reimbursement Scenario
      • 9.3.4.5 India Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5 South Korea
      • 9.3.5.1 Target Disease Prevalence
      • 9.3.5.2 Competitive Scenario
      • 9.3.5.3 Regulatory Framework
      • 9.3.5.4 Reimbursement Scenario
      • 9.3.5.5 South Korea Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6 Australia
      • 9.3.6.1 Target Disease Prevalence
      • 9.3.6.2 Competitive Scenario
      • 9.3.6.3 Regulatory Framework
      • 9.3.6.4 Reimbursement Scenario
      • 9.3.6.5 Australia Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7 Thailand
      • 9.3.7.1 Target Disease Prevalence
      • 9.3.7.2 Competitive Scenario
      • 9.3.7.3 Regulatory Framework
      • 9.3.7.4 Reimbursement Scenario
      • 9.3.7.5 Thailand Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4 Latin America
    • 9.4.1 Swot Analysis:
    • 9.4.2 Key Regional Dynamics
      • 9.4.2.1 Latin America Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3 Brazil
      • 9.4.3.1 Target Disease Prevalence
      • 9.4.3.2 Competitive Scenario
      • 9.4.3.3 Regulatory Framework
      • 9.4.3.4 Reimbursement Scenario
      • 9.4.3.5 Brazil Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4 Mexico
      • 9.4.4.1 Target Disease Prevalence
      • 9.4.4.2 Competitive Scenario
      • 9.4.4.3 Regulatory Framework
      • 9.4.4.4 Reimbursement Scenario
      • 9.4.4.5 Mexico Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5 Argentina
      • 9.4.5.1 Target Disease Prevalence
      • 9.4.5.2 Competitive Scenario
      • 9.4.5.3 Regulatory Framework
      • 9.4.5.4 Reimbursement Scenario
      • 9.4.5.5 Argentina Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5 Middle East & Africa (MEA)
    • 9.5.1 SWOT ANALYSIS:
    • 9.5.2 KEY regional DYNAMICS
      • 9.5.2.1 Middle East & Africa Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3 SOUTH AFRICA
      • 9.5.3.1 Target Disease Prevalence
      • 9.5.3.2 Competitive Scenario
      • 9.5.3.3 Regulatory Framework
      • 9.5.3.4 Reimbursement Scenario
      • 9.5.3.5 south Africail Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4 Saudi Arabia
      • 9.5.4.1 Target Disease Prevalence
      • 9.5.4.2 Competitive Scenario
      • 9.5.4.3 Regulatory Framework
      • 9.5.4.4 Reimbursement Scenario
      • 9.5.4.5 Saudi Arabia Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5 UAE
      • 9.5.5.1 Target Disease Prevalence
      • 9.5.5.2 Competitive Scenario
      • 9.5.5.3 Regulatory Framework
      • 9.5.5.4 Reimbursement Scenario
      • 9.5.5.5 UAE Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6 Kuwait
      • 9.5.6.1 Target Disease Prevalence
      • 9.5.6.2 Competitive Scenario
      • 9.5.6.3 Regulatory Framework
      • 9.5.6.4 Reimbursement Scenario
      • 9.5.6.5 Kuwait Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10 Gene Synthesis Market: Company Profiling

  • 10.1 Company Profiles
    • 10.1.1 GenScript
      • 10.1.1.1 Company overview
      • 10.1.1.2 Financial performance
      • 10.1.1.3 Product benchmarking
      • 10.1.1.4 Strategic initiatives
    • 10.1.2 Brooks Automation, Inc. (GENEWIZ)
      • 10.1.2.1 Company overview
      • 10.1.2.2 Financial performance
      • 10.1.2.3 Product benchmarking
      • 10.1.2.4 Strategic initiatives
    • 10.1.3 Boster Biological Technology
      • 10.1.3.1 Company overview
      • 10.1.3.2 Financial performance
      • 10.1.3.3 Product benchmarking
      • 10.1.3.4 Strategic initiatives
    • 10.1.4 Twist Bioscience
      • 10.1.4.1 Company overview
      • 10.1.4.2 Financial performance
      • 10.1.4.3 Product benchmarking
      • 10.1.4.4 Strategic initiatives
    • 10.1.5 ProteoGenix, Inc.
      • 10.1.5.1 Company overview
      • 10.1.5.2 Financial performance
      • 10.1.5.3 Product benchmarking
      • 10.1.5.4 Strategic initiatives
    • 10.1.6 Biomatik
      • 10.1.6.1 Company overview
      • 10.1.6.2 Financial performance
      • 10.1.6.3 Product benchmarking
      • 10.1.6.4 Strategic initiatives
    • 10.1.7 ProMab Biotechnologies, Inc.
      • 10.1.7.1 Company overview
      • 10.1.7.2 Financial performance
      • 10.1.7.3 Product benchmarking
      • 10.1.7.4 Strategic initiatives
    • 10.1.8 Thermo Fisher Scientific, Inc.
      • 10.1.8.1 Company overview
      • 10.1.8.2 Financial performance
      • 10.1.8.3 Product benchmarking
      • 10.1.8.4 Strategic initiatives
    • 10.1.9 Integrated DNA Technologies, Inc.
      • 10.1.9.1 Company overview
      • 10.1.9.2 Financial performance
      • 10.1.9.3 Product benchmarking
      • 10.1.9.4 Strategic initiatives
    • 10.1.10 OriGene Technologies, Inc.
      • 10.1.10.1 Company overview
      • 10.1.10.2 Financial performance
      • 10.1.10.3 Product benchmarking
      • 10.1.10.4 Strategic initiatives
  • 10.2 List of Other Key Players

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 4 Global Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 5 Global Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 7 Global Gene Synthesis Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 10 North America Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 11 North America Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 14 U.S. Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 15 U.S. Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 17 Canada Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 18 Canada Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 19 Canada Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 20 Canada Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 21 Europe Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 23 Europe Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 24 Europe Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 25 Europe Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 26 Germany Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 27 Germany Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 28 Germany Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 30 UK Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 31 UK Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 32 UK Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 33 UK Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 34 France Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 35 France Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 36 France Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 37 France Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 38 Italy Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 39 Italy Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 40 Italy Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 41 Italy Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 42 Spain Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 43 Spain Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 44 Spain Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 45 Spain Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 46 Denmark Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 47 Denmark Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 48 Denmark Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 49 Denmark Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 50 Sweden Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 51 Sweden Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 52 Sweden Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 53 Sweden Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 54 Norway Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 55 Norway Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 56 Norway Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 57 Norway Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 63 China Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 64 China Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 65 China Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 66 China Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 67 Japan Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 68 Japan Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 69 Japan Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 70 Japan Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 71 India Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 72 India Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 73 India Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 74 India Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 75 Australia Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 76 Australia Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 77 Australia Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 78 Australia Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 79 Thailand Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 80 Thailand Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 81 Thailand Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 82 Thailand Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 83 South Korea Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 84 South Korea Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 85 South Korea Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Korea Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 87 Latin America Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 89 Latin America Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 90 Latin America Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 91 Latin America Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 92 Brazil Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 93 Brazil Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 94 Brazil Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 95 Brazil Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 96 Mexico Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 97 Mexico Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 98 Mexico Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 99 Mexico Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 101 Argentina Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 102 Argentina Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 103 Argentina Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 110 South Africa Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 111 South Africa Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 112 South Africa Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 117 UAE Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 118 UAE Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 119 UAE Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 120 UAE Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain - Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Gene Synthesis, Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
  • Fig. 16 Global Gene Synthesis Market, : Method Movement Analysis
  • Fig. 17 Global Gene Synthesis Market, for Solid - phase Synthesis, 2018 - 2030 (USD Million)
  • Fig. 18 Global Gene Synthesis Market, for Chip - based Synthesis, 2018 - 2030 (USD Million)
  • Fig. 19 Global Gene Synthesis Market, for PCR - based Enzyme Synthesis, 2018 - 2030 (USD Million)
  • Fig. 20 Global Gene Synthesis Market, for Services, Movement Analysis
  • Fig. 21 Global Gene Synthesis Market, for Antibody DNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 22 Global Gene Synthesis Market, for Viral DNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 23 Global Gene Synthesis Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 24 Global Gene Synthesis Market, for Application, Movement Analysis
  • Fig. 25 Global Gene Synthesis Market, for Gene & Cell Therapy Development, 2018 - 2030 (USD Million)
  • Fig. 26 Global Gene Synthesis Market, for Vaccine Development, 2018 - 2030 (USD Million)
  • Fig. 27 Global Gene Synthesis Market, for Disease Diagnosis, 2018 - 2030 (USD Million)
  • Fig. 28 Global Gene Synthesis Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 Global Gene Synthesis Market, for End - use, Movement Analysis
  • Fig. 30 Global Gene Synthesis Market, for Biotechnology and pharmaceutical companies, 2018 - 2030 (USD Million)
  • Fig. 31 Global Gene Synthesis Market, for Academic and government research institutes, 2018 - 2030 (USD Million)
  • Fig. 32 Global Gene Synthesis Market, for Contract research organizations, 2018 - 2030 (USD Million)
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 Regional Outlook, 2022 & 2030
  • Fig. 35 Global Gene Synthesis Market, : Region Movement Analysis
  • Fig. 36 North America Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 64 Ansoff Matrix
  • Fig. 65 Market differentiators
  • Fig. 66 Key company market share analysis, 2022
  • Fig. 67 Company market position analysis
  • Fig. 68 Competitive dashboard analysis
  • Fig. 69 Regional network map